Instil Bio Inc (TIL) Event Aug. 12, 2022, 00:00 UTC (75% Positive) Instil Bio, Inc. (TIL) Reports 48% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 9:39 p.m. 🏢 Instil Bio Inc (TIL) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-12 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-58.44M $-113.11M $54.67M +48.33% 📉 Total Assets $609.98M $568.54M $41.45M +7.29% 📈 Total Liabilities $54.78M $110.20M $-55.42M -50.29% 📈 Stockholders' Equity $635.47M $-103.36M $738.83M +714.80% 📈 Operating Income/Loss $-58.78M $-113.01M $54.23M +47.98% 📉 R&D Expense $35.61M $80.67M $-45.06M -55.86% 📈 Earningspersharebasic $-0.71 $-0.88 $0.17 +19.32% 📈 Earningspersharediluted $-0.71 $-0.88 $0.17 +19.32% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Instil Bio Inc (TIL) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document